Search research articles
Contact Us
Filters
Showing results (71-80 of 220) with videos related to
Page
of 22
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
May 12, 2011
A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer
David R Spigel, John D Hainsworth, Howard A Burris, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 28, 2010
Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer
David R Spigel, John D Hainsworth, John H Barton, et al.
Clinical Breast Cancer
|
November 26, 2009
Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer
Denise A Yardley, Howard A Burris, Tiffanie Markus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 31, 2009
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
David R Spigel, F Anthony Greco, John D Zubkus, et al.
The Oncologist
|
March 11, 2022
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings
Emma G Sturgill, Amanda Misch, Carissa C Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 7, 2007
Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network
David R Spigel, John D Hainsworth, Lisa Simons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2010
Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction
David R Spigel, F Anthony Greco, Anthony A Meluch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2018
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
John D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer Investigation
|
February 18, 2010
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium
John D Hainsworth, Anthony A Meluch, Cassie M Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Reply to J.J. Tao et al
John D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 220) with videos related to
Sort By:
Page
of 22
Clinical Advances in Hematology & Oncology : H&O
|
May 12, 2011
A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer
David R Spigel, John D Hainsworth, Howard A Burris, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 28, 2010
Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer
David R Spigel, John D Hainsworth, John H Barton, et al.
Clinical Breast Cancer
|
November 26, 2009
Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer
Denise A Yardley, Howard A Burris, Tiffanie Markus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 31, 2009
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
David R Spigel, F Anthony Greco, John D Zubkus, et al.
The Oncologist
|
March 11, 2022
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings
Emma G Sturgill, Amanda Misch, Carissa C Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 7, 2007
Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network
David R Spigel, John D Hainsworth, Lisa Simons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2010
Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction
David R Spigel, F Anthony Greco, Anthony A Meluch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2018
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
John D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer Investigation
|
February 18, 2010
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium
John D Hainsworth, Anthony A Meluch, Cassie M Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Reply to J.J. Tao et al
John D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Page
of 22